A Weill Cornell Medicine study published in the Proceedings of the National Academy of Sciences in August 2026 reveals that regional dips in oxygen levels coordinate heart muscle and blood vessel growth during development. Using zebrafish models, researchers found that epicardial cells detect hypoxia and activate genes to orchestrate expansion. This self-limiting feedback loop prevents excessive muscle stiffening, offering potential therapeutic targets for human heart failure.
Hypoxia-mediated heart development coordination
- ▪A study led by Weill Cornell Medicine researchers found that regional dips in oxygen levels trigger the coordinated growth of heart muscle and coronary vessels during development.
- ▪The hypoxia-responsive program in developing hearts operates as a self-limiting feedback loop where muscle growth outstripping vessel expansion triggers hypoxia, which stimulates vasculature growth to supply oxygen and dampen the signal.
Epicardial cell signaling mechanism
- ▪Destroying epicardial cells in zebrafish mutants that fail to develop coronary vessels blocks the excessive, stiffening expansion of heart muscle, confirming the epicardium's orchestrating role.
- ▪Researchers discovered that epicardial cells surrounding the developing heart detect low oxygen levels and activate a suite of genes that orchestrate both muscle and vasculature expansion.
Zebrafish cardiac research model
- ▪The study, published in the Proceedings of the National Academy of Sciences in August 2026, utilized zebrafish to investigate how coronary vessels develop and synchronize with muscle tissue.
- ▪Live-cell imaging of developing zebrafish hearts by Weill Cornell Medicine researchers revealed no clear leader-follower relationship, as muscle and vessels expanded coordinately without one consistently arriving first.
Heart failure therapeutic implications
- ▪The conserved genes and hypoxia-responsive system identified in zebrafish may play a role in human heart failure, which displays similar patterns of muscle stiffening and vascular disruption.
- ▪Dr. Michael Harrison of Weill Cornell Medicine stated that targeting developmental signaling pathways or their producing cells could alter the trajectory or slow the progression of cardiovascular conditions leading to heart failure.
Story comments
Loading comments…